After an initial Hermansky-Pudlak syndrome clinical diagnosis, molecular testing reveals variants for oculocutaneous albinism type 1B: A case report.
Joseline Serrano-GonzálezIngrid Montes-RodríguezJessicca Y RentaRicardo RojasCarmen L CadillaPublished in: Molecular genetics & genomic medicine (2024)
Our study shows the importance of molecular testing when diagnosing a rare genetic disorder, especially in populations were the disease prevalence is higher.